Related Experiment Video
Updated: Sep 26, 2026

Breast Milk Enhances Growth of Enteroids: An Ex Vivo Model of Cell Proliferation
Published on: February 15, 2018
Risk of infantile hypertrophic pyloric stenosis after maternal postnatal use of macrolides
Henrik Toft Sørensen1, Mette Vinther Skriver, Lars Pedersen
1Department of Clinical Epidemiology, Aarhus University Hospital and Aalborg Hospital, Aarhus, Denmark. hts@soci.au.dk
Insights
Macrolide antibiotics transmitted via breast milk may increase the risk of infantile hypertrophic pyloric stenosis in newborns. This finding highlights potential risks associated with breastfeeding after maternal macrolide exposure.
Area of Science:
- Neonatal health
- Pharmacology
- Pediatric gastroenterology
Background:
- A previous case report suggested a link between erythromycin in breast milk and infantile hypertrophic pyloric stenosis (IHPS).
- Macrolide antibiotics are commonly prescribed and can be transmitted to infants through breast milk.
Purpose of the Study:
- To investigate the association between maternal macrolide use during breastfeeding and the risk of infantile hypertrophic pyloric stenosis (IHPS) in neonates.
Main Methods:
- A population-based cohort study utilizing Danish prescription, birth, and hospital discharge registries.
- Included 1166 women prescribed macrolides from birth to 90 days postpartum and 34,690-41,778 control women.
- Analyzed odds ratios for IHPS based on postnatal macrolide exposure, stratified by infant gender.
Main Results:
- Macrolide use during breastfeeding was associated with an increased risk of IHPS.
- Odds ratios ranged from 2.3 to 3.0 for different postnatal exposure periods.
- Gender-specific analysis showed a significantly higher risk in girls (OR 10.3) compared to boys (OR 2.0).
Conclusions:
- Maternal macrolide use while breastfeeding elevates the risk of infantile hypertrophic pyloric stenosis in neonates.
- The association appears stronger in female infants.
- This study underscores the importance of considering antibiotic exposure risks during breastfeeding.
Abstract:
A case report has suggested that exposure to erythromycin through breast milk might cause infantile hypertrophic pyloric stenosis. This study therefore examined whether macrolides, transmitted via breast milk, increase the risk of infantile hypertrophic pyloric stenosis in neonates. A population-based cohort study was conducted, based on data from a prescription registry, the Danish Birth Registry and North Jutland County's hospital discharge registry, Denmark, and comprising 1166 pregnant women who had been prescribed macrolides from birth to 90 d postnatally, and 34,690-41,778 pregnant women as controls. The odds ratios for infantile hypertrophic pyloric stenosis varied between 2.3 and 3.0 according to different periods of postnatal exposure, and after stratification for gender they were 10.3 [95% confidence interval (95% CI) 1.2-92.3] for girls and 2.0 (95% CI 0.5-8.4) for boys. The use of macrolides during breast-feeding increases the risk of infantile hypertrophic pyloric stenosis.
More Related Videos
09:36Effect of Hyaluronic Acid 35 kDa on an In Vitro Model of Preterm Small Intestinal Injury and Healing Using Enteroid-Derived Monolayers
Published on: July 28, 2022
08:50A Murine Model of Fetal Exposure to Maternal Inflammation to Study the Effects of Acute Chorioamnionitis on Newborn Intestinal Development
Published on: June 24, 2020
Related Concept Videos
Gastritis II: Pathophysiology
Pyloric Obstruction
Peptic Ulcer
Development of the Oral Microbiota
Esophageal Strictures-I: Introduction
Etiology
The primary cause of esophageal strictures is long-standing gastroesophageal reflux disease (GERD), accounting for about 70 to 80% of adult cases. Chronic acid reflux can lead to injury and scarring of the esophageal lining, culminating in...
Microbiota Modulation by Antibiotics